Ingevity Corp

NGVT · XNYS

CIK 1653477fmd_1X7V6ZRR67GSC0W3Y2MCCN1M2SManufacturing · Chemicals & Allied ProductsTemplate: Standard

Coverage: Jan 01, 2014 to Sep 30, 2026, 48 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	908	972	1,134	1,293	1,216	1,392	1,668	1,216	1,200	1,168
Cost of revenue	634	643	717	811	751	879	1,098	771	735	706
Gross profit	274	329	417	482	466	513	570	445	465	462
Research and development	18	20	22	20	23	26	30	25	25	28
Selling, general and administrative	96	106	132	163	149	179	199	162	158	171
Operating income	164	243	321	397	398	422	453	423	426	419
Interest expense	19	18	33	55	47	52	62	93	98	78
Interest and investment income	–	2	3	8	5	4	8	6	8	5
Other non-operating income (expense)	3	(1)	(1)	4	4	(80)	2	16	(8)	(25)
Income before taxes	87	175	222	228	235	163	270	130	(141)	(142)
Income tax expense	43	30	40	44	54	45	58	24	(19)	8
Net income from continuing operations	44	145	182	184	181	118	212	106	(121)	(150)
Net income	35	127	169	184	181	118	212	(5)	(430)	(167)